Brault, C.; Brind’Amour, A.; de Guerke, L.; Auclair, M.-H.; Sideris, L.; Dubé, P.; Soucisse, M.; Tremblay, J.-F.; Bernard, L.; Piedimonte, S.;
et al. Combined Interval Cytoreductive Surgery and Carboplatin-Based Hyperthermic Intraperitoneal Chemotherapy in Advanced Primary High-Grade Serous Ovarian Cancer. Curr. Oncol. 2023, 30, 10272-10282.
https://doi.org/10.3390/curroncol30120748
AMA Style
Brault C, Brind’Amour A, de Guerke L, Auclair M-H, Sideris L, Dubé P, Soucisse M, Tremblay J-F, Bernard L, Piedimonte S,
et al. Combined Interval Cytoreductive Surgery and Carboplatin-Based Hyperthermic Intraperitoneal Chemotherapy in Advanced Primary High-Grade Serous Ovarian Cancer. Current Oncology. 2023; 30(12):10272-10282.
https://doi.org/10.3390/curroncol30120748
Chicago/Turabian Style
Brault, Claudèle, Alexandre Brind’Amour, Lara de Guerke, Marie-Hélène Auclair, Lucas Sideris, Pierre Dubé, Mikaël Soucisse, Jean-François Tremblay, Laurence Bernard, Sabrina Piedimonte,
and et al. 2023. "Combined Interval Cytoreductive Surgery and Carboplatin-Based Hyperthermic Intraperitoneal Chemotherapy in Advanced Primary High-Grade Serous Ovarian Cancer" Current Oncology 30, no. 12: 10272-10282.
https://doi.org/10.3390/curroncol30120748
APA Style
Brault, C., Brind’Amour, A., de Guerke, L., Auclair, M.-H., Sideris, L., Dubé, P., Soucisse, M., Tremblay, J.-F., Bernard, L., Piedimonte, S., & Fortin, S.
(2023). Combined Interval Cytoreductive Surgery and Carboplatin-Based Hyperthermic Intraperitoneal Chemotherapy in Advanced Primary High-Grade Serous Ovarian Cancer. Current Oncology, 30(12), 10272-10282.
https://doi.org/10.3390/curroncol30120748
